“布呋洛尔”、“右美沙芬”-"bufuralol","dextromethorphan"
注释ID
1446898923
变量_单倍型
CYP2D6*1, CYP2D6*17
基因
CYP2D6
药物名称(英)
"bufuralol","dextromethorphan"
药物名称(中)
“布呋洛尔”、“右美沙芬”
PMID
11950793
类型
Metabolism/PK
含义
yes
记事
The *17 construct (T107I, R296C and S486T) was expressed in cos-7 cells and the kinetic parameters Km and Vmax were determined for dextromethorphan and bufuralol compared to *1 construct. dextromethorphan: Km 2 fold increase to *1; Vmax 33% reduction. bufuralol: Km no effect compared to *1; Vmax 45% decrease compared to *1. Resulting in about 25 % (p<0.01) reduction in intrinsic clearance for dextromethorphan and 37% (p<0.02) for bufuralol for *17 compared to *1. CYP2D6 cDNA with *17=T105I, R296C; S486T variations. The intrinsic clearance for these substrates are also lower from *17 compared to *2 (p<0.05).
专家论述
CYP2D6 *17 is associated with decreased clearance of bufuralol or dextromethorphan in COS-7 cells as compared to CYP2D6 *1.
等位基因
*17
专家评论
变体注释摘要
id研究类型特征类型
26816 Drug
26815 Drug
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3